Literature DB >> 32226192

Influenza pandemics: past, present and future challenges.

Antoine Flahault1, Patrick Zylberman2.   

Abstract

Influenza epidemics occur regularly and prediction of their conversion to pandemics and their impact is difficult. Coordination of efforts on a global scale to control or reduce the impact is fraught with potential for under and overreaction. In light of the 1956 pandemic and more recently the SARS and H1N1 pandemics, the public health community took steps toward strengthening global surveillance and a coordinated response in keeping with the continuing memory of the tragedy seen in 1918. The scientific, professional, and technical resources of the 21st century are now advanced far beyond those then available. The H1N1 pandemic which commenced in 2009 progressed differently than predicted; its course was difficult to predict with any degree of certainty. Public responses to national immunization programs against the H1N1 virus have been weak. International movement of diseases can lead to creation of new endemic areas and continuous spread such as that which happened with West Nile Fever and Chikungunya. The lessons learned and the public and political responses to each actual or threatened pandemic will serve public health well in dealing with future challenges. © BioMed Central London 2010.

Entities:  

Keywords:  1976; SARS; antivirals; global influenza monitoring; influenza A (H1N1); influenza policy; pandemic 1918; vaccination

Year:  2010        PMID: 32226192      PMCID: PMC7099366          DOI: 10.1007/BF03391605

Source DB:  PubMed          Journal:  Public Health Rev        ISSN: 0301-0422


  41 in total

1.  WHO extends its SARS-related travel advice to Beijing and Shanxi Province (China) and to Toronto (Canada), 23 April 2003.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2003-04-25

2.  Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database.

Authors:  Julia Stowe; Nick Andrews; Lesley Wise; Elizabeth Miller
Journal:  Am J Epidemiol       Date:  2008-11-24       Impact factor: 4.897

3.  Summary of clinical trials of inactivated influenza vaccine - 1978.

Authors:  J R La Montagne; G R Noble; G V Quinnan; G T Curlin; W C Blackwelder; J I Smith; F A Ennis; F M Bozeman
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

4.  Critically ill patients with 2009 influenza A(H1N1) infection in Canada.

Authors:  Anand Kumar; Ryan Zarychanski; Ruxandra Pinto; Deborah J Cook; John Marshall; Jacques Lacroix; Tom Stelfox; Sean Bagshaw; Karen Choong; Francois Lamontagne; Alexis F Turgeon; Stephen Lapinsky; Stéphane P Ahern; Orla Smith; Faisal Siddiqui; Philippe Jouvet; Kosar Khwaja; Lauralyn McIntyre; Kusum Menon; Jamie Hutchison; David Hornstein; Ari Joffe; Francois Lauzier; Jeffrey Singh; Tim Karachi; Kim Wiebe; Kendiss Olafson; Clare Ramsey; Sat Sharma; Peter Dodek; Maureen Meade; Richard Hall; Robert A Fowler
Journal:  JAMA       Date:  2009-10-12       Impact factor: 56.272

5.  Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-10-02       Impact factor: 17.586

6.  Reflections on the 1976 swine flu vaccination program.

Authors:  David J Sencer; J Donald Millar
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

7.  The swine flu episode and the fog of epidemics.

Authors:  Richard Krause
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

8.  Influenza pandemics of the 20th century.

Authors:  Edwin D Kilbourne
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

9.  Influenza activity in Europe during eight seasons (1999-2007): an evaluation of the indicators used to measure activity and an assessment of the timing, length and course of peak activity (spread) across Europe.

Authors:  John Paget; Richard Marquet; Adam Meijer; Koos van der Velden
Journal:  BMC Infect Dis       Date:  2007-11-30       Impact factor: 3.090

Review 10.  Pandemic (H1N1) 2009 influenza.

Authors:  M Patel; A Dennis; C Flutter; Z Khan
Journal:  Br J Anaesth       Date:  2010-01-05       Impact factor: 9.166

View more
  1 in total

Review 1.  An update on emerging therapeutics to combat COVID-19.

Authors:  Naveed Nazir Shah; Showkat Ul Nabi; Muzafar Ahmad Rather; Qudratullah Kalwar; Sofi Imtiyaz Ali; Wajid Mohammad Sheikh; Alveena Ganai; Showkeen Muzamil Bashir
Journal:  Basic Clin Pharmacol Toxicol       Date:  2021-06-11       Impact factor: 3.688

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.